Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis

JA Stone, JB McCrea, R Witter, S Zajic… - British journal of …, 2019 - Wiley Online Library
Cathepsin K (CatK) is a cysteine protease abundantly expressed by osteoclasts and
localized in the lysosomes and resorption lacunae of these cells. CatK is the principal …

[HTML][HTML] Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis

JA Stone, JB McCrea, R Witter, S Zajic… - British Journal of …, 2019 - ncbi.nlm.nih.gov
Cathepsin K (CatK) is a cysteine protease abundantly expressed by osteoclasts and
localized in the lysosomes and resorption lacunae of these cells. CatK is the principal …

Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis.

JA Stone, JB McCrea, R Witter, S Zajic… - British Journal of …, 2019 - europepmc.org
Cathepsin K (CatK) is a cysteine protease abundantly expressed by osteoclasts and
localized in the lysosomes and resorption lacunae of these cells. CatK is the principal …

Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis.

JA Stone, JB McCrea, R Witter… - British Journal of …, 2019 - search.ebscohost.com
Cathepsin K (CatK) is a cysteine protease abundantly expressed by osteoclasts and
localized in the lysosomes and resorption lacunae of these cells. CatK is the principal …

Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis

JA Stone, JB McCrea, R Witter… - British journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Cathepsin K (CatK) is a cysteine protease abundantly expressed by osteoclasts and
localized in the lysosomes and resorption lacunae of these cells. CatK is the principal …